Skip to main content

Preparation and Characterization of Photosensitive and Magnetic Targeting Graphene Oxide Nanocomposite

Buy Article:

$107.14 + tax (Refund Policy)

Hematoporphyrin-conjugatedmagnetic graphene oxide nanocomposite was designed and prepared as a novel promising model. Fe3O4 nanoparticles were dispersed on the surface and edges of the graphene oxide in a uniform size, and hematoporphyrin was effectively conjugated onto grapheme oxide via hydrophobic interactions and ππ stacking. With the photosensitivity of hematoporphyrin and the magnetic properties of Fe3O4 nanoparticles, it can be applied for photodynamic therapy to increase the accumulation of hematoporphyrin in tumor cells. The cytotoxicity in vitro showed that hematoporphyrin conjugated magnetic graphene oxide nanocomposite irradiated at 671 nm generated cytotoxic singlet oxygen and exhibited a good inhibition to the human tumor cell HeLa (IC50 = 10.12 μg/ml), which suggested that the nanocomposite is potential for targeting photodynamic therapy as a promising drug delivery system.

Document Type: Research Article

Publication date: 01 March 2015

More about this publication?
  • Journal for Nanoscience and Nanotechnology (JNN) is an international and multidisciplinary peer-reviewed journal with a wide-ranging coverage, consolidating research activities in all areas of nanoscience and nanotechnology into a single and unique reference source. JNN is the first cross-disciplinary journal to publish original full research articles, rapid communications of important new scientific and technological findings, timely state-of-the-art reviews with author's photo and short biography, and current research news encompassing the fundamental and applied research in all disciplines of science, engineering and medicine.
  • Editorial Board
  • Information for Authors
  • Subscribe to this Title
  • Terms & Conditions
  • Ingenta Connect is not responsible for the content or availability of external websites
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content